Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

CLIENT ALERT: CMS Unveils New Price Transparency Rules

Client Alert

On November 15th, the Trump administration announced historic price transparency requirements to increase competition and lower healthcare costs for all Americans.  In response to President Trump’s Executive Order signed in July 2019, the Department of Health and Human Services took action to advance the Trump administration’s commitment to increasing price transparency in the health care industry and promote public access to hospital standard charges.[1] The announcement focuses on a final rule and a proposed rule.

The final rule requires hospitals to display their secret, negotiated rates to patients starting in January 2021. Hospitals will be required to make public all “standard charges” online in a single data file that can be read by other computers. “Standard charges” include gross charges, payer-specific negotiated charges, the amount the hospital is willing to accept in cash from a patient, and minimum and maximum negotiated charges.[2] Other items and services that must be disclosed include supplies, facility fees, and professional charges for employed physicians and other practitioners. This information and format will be most useful for employers, providers, and tool developers when designing consumer-friendly price transparency tools in the future.

Hospitals also need to make public the standard charges for at least 300 common “shoppable services” and describe this information in plain language. “Shoppable services” include x-rays, outpatient visits, imaging and laboratory tests.[3] This information must be easily accessible, in a searchable format, and be updated annually.[4] The goal of this requirement is to ensure that healthcare consumers can compare services between different hospitals and mitigate cost surprises. [5] Of the 300 shoppable services, the rule specifies 70 services that must be included (see table below for the required 70 services). The other 230 services will be chosen by the hospital. In order to ensure compliance with the final rule, the Centers of Medicare & Medicaid Services (“CMS”) has the authority to impose fines on the hospital up to $300 per day and $109,500 for the entire year. Some critics of the final rule argue this monetary penalty will be an insufficient enforcement tool given the relatively insignificant amount a hospital will be forced to pay.[6] Other enforcement tools include monitoring hospital compliance, evaluating complaints made by individuals and entities sent to CMS, and auditing hospital websites.[7]

The second rule discussed in the announcement is a proposal that would require insurance companies to show patients their expected out-of-pocket costs instantly through an online tool or in paper form, if requested. If finalized, the Transparency in Coverage proposed rule would also require health insurance companies and group health plans that cover employees to disclose on a public website their negotiated rates for in-network providers and allowed amounts for out-of-network providers.[8] Insurers would need to explain how much a service would cost, the amount an insurance plan would pay, and how much the consumer would owe before the service is rendered.[9] This requirement is intended to promote informed and price-conscious decision making and drive competition in the healthcare industry.[10] The proposed rule is subject to a 60-day public comment period. Comments are due by 5 p.m. on January 14, 2020 and may be submitted online at https://www.regulations.gov/ or by mail to the Centers for Medicare & Medicaid Services.

Summary:

These rules are a historic step toward price transparency across the health care industry and are in furtherance of the Trump administration’s goal of empowering healthcare consumers. The finalized rule and the proposed rule strive to make pricing information more available to healthcare consumers so they can make informed health care decisions. Through price transparency, consumers should expect to see a reduction in healthcare costs in the future. In order to provide hospitals enough time for compliance with the new requirements, the effective date of the finalized rule is January 1, 2021. The comment period for the proposed rule is open until January 14, 2020.

Please contact a BMD healthcare attorney if you have any questions on the new price transparency rule or would like to submit written comments for the proposed rule, if you have any questions on how these rules may affect your practice, or if you have any other healthcare related questions in general. 

TABLE 3—FINAL LIST OF 70 CMS-SPECIFIED SHOPPABLE SERVICES Evaluation & Management Services [11]

2020 CPT/HCPCS Primary Code

Psychotherapy, 30 min

90832

Psychotherapy, 45 min

90834

Psychotherapy, 60 min

90837

Family psychotherapy, not including patient, 50 min

90846

Family psychotherapy, including patient, 50 min

90847

Group psychotherapy

90853

New patient office or other outpatient visit, typically 30 min

99203

New patient office of other outpatient visit, typically 45 min

99204

New patient office of other outpatient visit, typically 60 min

99205

Patient office consultation, typically 40 min

99243

Patient office consultation, typically 60 min

99244

Initial new patient preventive medicine evaluation (18-39 years)

99385

Initial new patient preventive medicine evaluation (40-64 years)

99386

Laboratory & Pathology Services

2020 CPT/HCPCS Primary Code

Basic metabolic panel

80048

Blood test, comprehensive group of blood chemicals

80053

Obstetric blood test panel

80055

Blood test, lipids (cholesterol and triglycerides)

80061

Kidney function panel test

80069

Liver function blood test panel

80076

Manual urinalysis test with examination using microscope

81000 or 81001

Automated urinalysis test

81002 or 81003

PSA (prostate specific antigen)

84153-84154

Blood test, thyroid stimulating hormone (TSH)

84443

Complete blood cell count, with differential white blood cells, automated

85025

Complete blood count, automated

85027

Blood test, clotting time

85610

Coagulation assessment blood test

85730

Radiology Services

2020 CPT/HCPCS Primary Code

CT scan, head or brain, without contrast

70450

MRI scan of brain before and after contrast

70553

X-Ray, lower back, minimum four views

72110

MRI scan of lower spinal canal

72148

CT scan, pelvis, with contrast

72193

MRI scan of leg joint

73721

CT scan of abdomen and pelvis with contrast

74177

Ultrasound of abdomen

76700

Abdominal ultrasound of pregnant uterus (greater or equal to 14 weeks 0 days) single or first fetus

76805

Ultrasound pelvis through vagina

76830

Mammography of one breast

77065

Mammography of both breasts

77066

Mammography, screening, bilateral

77067

Medicine and Surgery Services

2020 CPT/HCPCS/DRG Primary Code

Cardiac valve and other major cardiothoracic procedures with cardiac catheterization with major complications or comorbidities

216

Spinal fusion except cervical without major comorbid conditions or complications (MCC)

460

Major joint replacement or reattachment of lower extremity without major comorbid conditions or complications (MCC).

470

Cervical spinal fusion without comorbid conditions (CC) or major comorbid conditions or complications (MCC).

473

Uterine and adnexa procedures for non-malignancy without comorbid conditions (CC) or major comorbid conditions or complications (MCC)

743

Removal of 1 or more breast growth, open procedure

19120

Shaving of shoulder bone using an endoscope

29826

Removal of one knee cartilage using an endoscope

29881

Removal of tonsils and adenoid glands patient younger than age 12

42820

Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope

43235

Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope

43239

Diagnostic examination of large bowel using an endoscope

45378

Biopsy of large bowel using an endoscope

45380

Removal of polyps or growths of large bowel using an endoscope

45385

Ultrasound examination of lower large bowel using an endoscope

45391

Removal of gallbladder using an endoscope

47562

Repair of groin hernia patient age 5 years or older

49505

Biopsy of prostate gland

55700

Surgical removal of prostate and surrounding lymph nodes using an endoscope

55866

Routine obstetric care for vaginal delivery, including pre-and post-delivery care

59400

Routine obstetric care for cesarean delivery, including pre-and post-delivery care

59510

Routine obstetric care for vaginal delivery after prior cesarean delivery including pre-and post-delivery care

59610

Injection of substance into spinal canal of lower back or sacrum using imaging guidance

62322-62323

Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance

64483

Removal of recurring cataract in lens capsule using laser

66821

Removal of cataract with insertion of lens

66984

Electrocardiogram, routine, with interpretation and report

93000

Insertion of catheter into left heart for diagnosis

93452

Sleep study

95810

Physical therapy, therapeutic exercise

97110

 

[1] CMS-1717-F2

[2] U.S. Dept. of Health & Human Serv., Trump Administration Announces Historic Price Transparency Requirements to Increase Competition and Lower Healthcare Costs for All Americans (Nov. 15, 2019), https://www.hhs.gov/about/news/2019/11/15/trump-administration-announces-historic-price-transparency-and-lower-healthcare-costs-for-all-americans.html

[3] Id.

[4] Id.

[5] Id.

[6] Steven Porter, Enforcing Hospital Price Transparency: Is $300 max daily fine big enough? HealthLeaders (Nov. 15, 2019), https://www.healthleadersmedia.com/finance/enforcing-hospital-price-transparency-300-max-daily-fine-big-enough

[7] CY 2020 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Requirements (CMS-1717-F2), Centers for Medicare & Medicaid Services (Nov. 15, 2019), https://www.cms.gov/newsroom/fact-sheets/cy-2020-hospital-outpatient-prospective-payment-system-opps-policy-changes-hospital-price

 [8] U.S. Dept. of Health & Human Serv., Trump Administration Announces Historic Price Transparency Requirements to Increase Competition and Lower Healthcare Costs for All Americans (Nov. 15, 2019), https://www.hhs.gov/about/news/2019/11/15/trump-administration-announces-historic-price-transparency-and-lower-healthcare-costs-for-all-americans.html

[9] Selena Simmons-Duffin, Trump Wants Insurers and Hospitals To Show Real Prices To Patients, NPR (Nov. 15, 2019), https://www.npr.org/sections/health-shots/2019/11/15/779707609/trump-wants-insurers-and-hospitals-to-show-real-prices-to-patients

[10] U.S. Dept. of Health & Human Serv., Trump Administration Announces Historic Price Transparency Requirements to Increase Competition and Lower Healthcare Costs for All Americans (Nov. 15, 2019), https://www.hhs.gov/about/news/2019/11/15/trump-administration-announces-historic-price-transparency-and-lower-healthcare-costs-for-all-americans.html

[11] CMS-1717-F2, https://www.hhs.gov/sites/default/files/cms-1717-f2.pdf

 


Investment Training for the Second and Third Generations

Consider this scenario. Mom and Dad started the business from the ground up. Over the decades it has expanded into a money-making machine. They are able to sell the business and it results in a multimillion-dollar payday for their labors. The excess money has allowed Mom and Dad to invest with various financial advising firms, several fund management groups, and directly with new startups and joint ventures. Their experience has made them savvy investors, with a detailed understanding of how much to invest, when, and where. They cannot justify formation of a full family office with dedicated investors to manage the funds, but Mom and Dad have set up a trust fund for the children to allow these investments to continue to grow over the years. Eventually, Mom and Dad pass. Their children enjoy the fruits of their labors, and, by the time the grandchildren are adults, Mom and Dad's savvy investments are gone.

Provider Relief Funds – Continued Confusion Regarding Reporting Requirements and Lost Revenues

In Fall 2020, HHS issued multiple rounds of guidance and FAQs regarding the reporting requirements for the Provider Relief Funds, the most recently published notice being November 2, 2020 and December 11, 2020. Specifically, the reporting portal for the use of the funds in 2020 was scheduled to open on January 15, 2021. Although there was much speculation as to whether this would occur. And, as of the date of this article, the portal was not opened.

Ohio S.B. 310 Loosens Practice Barrier for Advanced Practice Providers

S.B. 310, signed by Ohio Governor DeWine and effective from December 29, 2020 until May 1, 2021, provides flexibility regarding the regulatorily mandated supervision and collaboration agreements for physician assistants, certified nurse-midwives, clinical nurse specialists and certified nurse practitioners working in a hospital or other health care facility. Originally drafted as a bill to distribute federal COVID funding to local subdivisions, the healthcare related provisions were added to help relieve some of the stresses hospitals and other healthcare facilities are facing during the COVID-19 pandemic.

HHS Issues Opinion Regarding Illegal Attempts by Drug Manufacturers to Deny 340B Discounts under Contract Pharmacy Arrangements

The federal 340B discount drug program is a safety net for many federally qualified health centers, disproportionate share hospitals, and other covered entities. This program allows these providers to obtain discount pricing on drugs which in turn allows the providers to better serve their patient populations and provide their patients with access to vital health care services. Over the years, the 340B program has undergone intense scrutiny, particularly by drug manufacturers who are required by federal law to provide the discounted pricing.

S.B. 263 Protects 340B Covered Entities from Predatory Practices in Ohio

Just before the end of calendar year 2020 and at the end of its two-year legislative session, the Ohio General Assembly passed Senate Bill 263, which prohibits insurance companies and pharmacy benefit managers (“PBMs”) from imposing on 340B Covered Entities discriminatory pricing and other contract terms. This is a win for safety net providers and the people they serve, as 340B savings are crucial to their ability to provide high quality, affordable programs and services to patients.